PFS
DCPH

Prospera Financial Services’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Prospera Financial Services’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-571
Closed -$29K – 1634
2020
Q3 		$29K Buy
+571
New +$28K 0.01% 792

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Prospera Financial Services's DCPH Position: Q4 2020 in Review

Prospera Financial Services sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2020, closing a stake of 571 shares — an estimated $29K sold.

Prospera Financial Services first reported a position in DCPH in Q3 2020 and held it in 1 quarter. The position peaked at $29K in Q3 2020. 182 funds tracked by Wall St. Rank hold DCPH as of Q4 2020.

  • Prospera Financial Services reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Prospera Financial Services sold 571 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2020, an estimated $29K.
  • Prospera Financial Services first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Prospera Financial Services's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $29K in Q3 2020.
  • 182 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2020.

Based on Prospera Financial Services's 13F filing for Q4 2020, filed 12 Feb 2021.